Saxena, Neeraj K <br/><br/>
Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.  [electronic resource] 

 -  Gastroenterology  Nov 2010 
 - 1762-73, 1773.e1-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2010.07.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adiponectin--pharmacology<br/>Animals<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Carcinoma, Hepatocellular--metabolism<br/>Cell Proliferation--drug effects<br/>Disease Progression<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Liver Neoplasms, Experimental--metabolism<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Phosphorylation--drug effects<br/>RNA, Neoplasm--genetics<br/>Receptors, Adiponectin--biosynthesis<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured